ATL-202

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameATL-202
Drug Alias NameATL-801ATL-618ATL-264ATL-202ATL-901 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A